Suppr超能文献

中医药对新冠病毒肺炎有效:一项系统评价与荟萃分析

Traditional Chinese Medicine is effective for COVID-19: A systematic review and meta-analysis.

作者信息

Xu Jiayi, Liu Hongmei, Fan Yubo, Ji Baohua

机构信息

Department of Applied Mechanics, Beijing Institute of Technology, Beijing 100081, China.

Beijing Advanced Innovation Center for Biomedical Engineering, Beihang University, Beijing 100083, China.

出版信息

Med Nov Technol Devices. 2022 Dec;16:100139. doi: 10.1016/j.medntd.2022.100139. Epub 2022 May 4.

Abstract

Traditional Chinese Medicine (TCM) has played crucial roles in treating COVID-19 in China. But its effectiveness has not yet been widely realized/recognized over the world. We performed a systematic review and meta-analysis to investigate the clinical efficacy of TCM medicine in the treatment for COVID-19. We obtained the data of COVID-19 and traditional Chinese medicine from PubMed, MEDLINE, Web of Science and other databases, and searched from January 1, 2020 to January 26, 2022 to determine the randomized controlled trials (RCTs) without language restrictions. The review includes 26 randomized clinical trials including 2981 patients. The treatment of COVID-19 by TCM combined with conventional treatment is more effective than by pure conventional treatment in many aspects, including increasing of the effective rate [OR ​= ​2.47, 95%CI (1.85, 3.30), P ​< ​0.00001], fever disappearance rate [OR ​= ​3.68, 95%CI (1.95, 6.96), P ​< ​0.0001], fatigue disappearance rate [OR ​= ​3.15, 95%CI (1.60, 6.21), P ​= ​0.0009], cough disappearance rate [OR ​= ​2.89, 95%CI (1.84, 4.54), P ​< ​0.00001], expectoration disappearance rate [OR ​= ​5.94, 95%CI (1.98, 17.84), P ​= ​0.001], disappearance rate of shortness of breath [OR ​= ​2.57, 95%CI (1.13, 5.80), P ​= ​0.02], improvement rate of CT image [OR ​= ​2.43, 95%CI (1.86, 3.16), P ​< ​0.00001], and reduction of the hospitalization time [MD ​= ​-3.16, 95%CI (-3.75, -2.56), P ​< ​0.00001], and deterioration rate [OR ​= ​0.49, 95%CI (0.29, 0.83), P ​= ​0.007]. The findings of this meta-analysis suggest that TCM can effectively relieve symptoms, boosted patients' recovery, cut the rate of patients developing into severe conditions, and reduce the deterioration rate.

摘要

中医在中国治疗新冠肺炎过程中发挥了关键作用。但其疗效尚未在全球得到广泛认可。我们进行了一项系统评价和荟萃分析,以研究中药治疗新冠肺炎的临床疗效。我们从PubMed、MEDLINE、科学网等数据库中获取新冠肺炎和中药的数据,并检索了2020年1月1日至2022年1月26日期间的文献,以确定无语言限制的随机对照试验(RCT)。该评价纳入了26项随机临床试验,共2981例患者。中药联合常规治疗在治疗新冠肺炎方面,在多个方面比单纯常规治疗更有效,包括提高有效率[比值比(OR)=2.47,95%置信区间(CI)(1.85,3.30),P<0.00001]、发热消失率[OR=3.68,95%CI(1.95,6.96),P<0.0001]、乏力消失率[OR=3.15,95%CI(1.60,6.21),P=0.0009]、咳嗽消失率[OR=2.89,95%CI(1.84,4.54),P<0.00001]、咳痰消失率[OR=5.94,95%CI(1.98,17.84),P=0.001]、气短消失率[OR=2.57,95%CI(1.13,5.80),P=0.02]、CT影像改善率[OR=2.43,95%CI(1.86,3.16),P<0.00001]、缩短住院时间[平均差(MD)=-3.16,95%CI(-3.75,-2.56),P<0.00001]以及降低病情恶化率[OR=0.49,95%CI(0.29,0.83),P=0.007]。这项荟萃分析的结果表明,中药可以有效缓解症状,促进患者康复,降低患者发展为重症的比例,并降低病情恶化率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfe1/9066964/1601d8008001/gr1_lrg.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验